Briefing Paper Examines Funding For Global Health Product Development

Noting “the development of medicines, vaccines and diagnostic tools to stop preventable illnesses and deaths from treatable illnesses  has relied on significant investments from a handful of governments and philanthropic organizations,” the Center for Global Health Policy’s “Science Speaks” blog highlights a new briefing paper (.pdf) from the Global Health Technologies Coalition called “Financing,” which “examin[es] approaches, challenges and opportunities confronting nonprofit organizations developing products to target neglected and poverty related disease.” The blog states, “While the coalition’s first report in the series focused on challenges to identifying, developing and introducing products in settings of limited infrastructure and scientific capacity, the latest brief explores the roles that innovation, coordination and collaboration must play in continuing global health research and development” (Barton, 9/12).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.